Despite their added benefit in assisting physicians with clinical decision making, statistical prediction rules have not been widely used since their introduction in 1954.
Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.